Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,245 across all filing types
Latest filing 2023-03-23 Regulatory Filings
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Registrar and Share ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the loss of a share certificate and the issuance of a duplicate share certificate. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about informing the exchanges of a shareholder's request for a duplicate share certificate due to loss. There are no financial statements, earnings data, management discussion, or other report contents. The document is an official regulatory notification related to share certificates, not a financial report or meeting material. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-03-23 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the loss of a share certificate and the issuance of a duplicate share certificate. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about informing the exchanges of a shareholder's request for a duplicate share certificate due to loss. This is a regulatory announcement related to shareholding records and does not contain financial data, management discussion, voting results, or other report types. It is not a report or financial statement but a regulatory notification about share certificate status. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2023-03-23 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the completion of a US FDA inspection at the company's manufacturing unit. It references regulatory disclosure requirements under SEBI Regulation 30, which pertains to material event disclosures by listed companies. The content is an update about an inspection outcome and the company's planned response, not a financial report, audit, or management discussion. The document length is short (1735 characters) and serves as an announcement of a regulatory event rather than a detailed report or filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-18 English
This is to inform you that the United States Food and Drug Administration (US FDA) conducted a Pre-Approval Inspection (PAI) and Good Manufacturing Practice (GMP) inspection at the Company''s ....
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges regarding the completion of a US FDA inspection at the company's manufacturing unit. It references regulatory disclosure requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to material event disclosures. The content is an update about the inspection outcome and the company's response plan, not a financial report or detailed filing. The document length is short (1735 characters), and it serves as an announcement of a regulatory event rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-18 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the intimation of loss of a share certificate and the issuance of a duplicate share certificate. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is an announcement of a corporate action related to share certificates, not a financial report, earnings release, or management discussion. It does not contain financial data or detailed report content but is a regulatory notification to the exchanges. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-17 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the intimation of loss of a share certificate and the issuance of a duplicate share certificate. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about a specific shareholder's lost share certificate and the procedural update to the exchanges. There is no financial data, no report or presentation, no voting results, no management or board changes, no earnings or audit information, and no mention of dividends or capital changes. This type of filing is a regulatory announcement related to compliance and disclosure obligations but does not fit into any of the more specific categories like share issue, director dealings, or capital updates. Given the nature and content, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories. The document length is short and it is not announcing a report publication, so it is not RPA. Confidence is high due to clear regulatory context and content type.
2023-03-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.